Concepedia

Haiyan Pu

HP

Statistics

Publications

10

Citations

341

H-Index

10

Active since

2001

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Haiyan Pu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicinal chemistry, and enzyme inhibition.

Publications per year

2001–2022

10

Publications

10

Glutathione responsive nitric oxide release for enhanced photodynamic therapy by a porphyrinic MOF nanosystem

Mengtong Xia, Yu Yan, Haiyan Pu et al. · Chemical Engineering Journal · 2022 · 74 citations

, , +16

Two new bacterial DNA primase inhibitors from the plant Polygonum cuspidatum

Vinod R. Hegde, Haiyan Pu, Mahesh Patel et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 53 citations

, , +11

I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles

G. Anilkumar, Charles A. Lesburg, Oleg Selyutin et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 49 citations

, , +14

Two antiviral compounds from the plant Stylogne cauliflora as inhibitors of HCV NS3 protease

Vinod R. Hegde, Haiyan Pu, Mahesh Patel et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 36 citations · Full text

, , +16

A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors

Kevin X. Chen, Charles A. Lesburg, Bancha Vibulbhan et al. · Journal of Medicinal Chemistry · 2012 · 27 citations

, , +17

1–5 of 10